Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)
Condition: Diabetic Foot Infection Interventions: Drug: contezolid acefosamil (IV)/contezolid (PO); Drug: Linezolid (IV and PO) Sponsor: MicuRx Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 11, 2022 Category: Research Source Type: clinical trials
